BC Innovations | Sep 10, 2015
Distillery Therapeutics

Therapeutics: Nuclear receptor coactivator 1 (NCOA1; SRC1); NCOA2 (SRC2); NCOA3 (SRC3; AIB1)

Cancer INDICATION: Cancer In vitro and mouse studies suggest co-stimulating NCOA1 , NCOA2 and NCOA3 could help treat cancer. In multiple human cancer cell lines, a small molecule research compound that stimulated NCOA1, NCOA2 and NCOA3...
BC Innovations | Dec 18, 2008
Distillery Therapeutics

This week in therapeutics

The Distillery: Therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Metabolic disease Von Gierke's disease Glucose-6-phosphatase catalytic subunit (G6PC; G6Pase); nuclear receptor coactivator 2 (NCOA2; SRC2); RAR-related orphan receptor-a (RORa) Studies in mice...
Items per page:
1 - 2 of 2